Latest Ratios: P/E Ratio 12.0x · EV/EBITDA 9.8x · ROE 20.6%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $13.1B | $11.3B | $9.5B | $11.7B | $11.9B | $9.7B | $10.2B | $11.7B | $8.6B | $10.8B | $9.0B |
| Enterprise Value | $15.6B | $13.8B | $12.0B | $13.7B | $13.9B | $11.6B | $12.0B | $13.3B | $10.1B | $12.1B | $10.3B |
| P/E Ratio → | 12.00 | 9.95 | 9.34 | 12.09 | 13.34 | 12.98 | 13.92 | 15.41 | 12.26 | 7.42 | 16.43 |
| P/S Ratio | 2.18 | 1.89 | 1.64 | 2.15 | 2.28 | 1.89 | 2.15 | 2.59 | 1.99 | 2.60 | 2.29 |
| P/B Ratio | 2.28 | 1.89 | 1.78 | 2.61 | 3.02 | 1.12 | 1.16 | 1.61 | 1.59 | 1.73 | 1.98 |
| P/FCF | 10.45 | 9.02 | 7.10 | 8.19 | 8.56 | 6.91 | 7.10 | 8.87 | 6.97 | 7.66 | 6.57 |
| P/OCF | 9.38 | 8.10 | 6.74 | 7.91 | 8.39 | 6.73 | 6.90 | 8.60 | 6.72 | 7.55 | 6.45 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.30 | 2.08 | 2.52 | 2.66 | 2.27 | 2.53 | 2.94 | 2.35 | 2.92 | 2.63 |
| EV / EBITDA | 9.79 | 8.66 | 8.27 | 10.60 | 11.67 | 8.54 | 12.21 | 13.09 | 10.62 | 13.26 | 12.09 |
| EV / EBIT | 10.65 | 8.66 | 8.27 | 10.60 | 11.67 | 8.54 | 12.21 | 13.09 | 10.62 | 13.26 | 12.09 |
| EV / FCF | — | 11.00 | 9.03 | 9.59 | 9.98 | 8.29 | 8.37 | 10.06 | 8.22 | 8.61 | 7.53 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 33.4% | 33.4% | 32.4% | 30.1% | 29.5% | 32.9% | 27.1% | 29.1% | 28.8% | 93.8% | 27.6% |
| Operating Margin | 24.4% | 24.4% | 23.0% | 21.9% | 21.1% | 24.9% | 18.9% | 20.6% | 20.0% | 22.2% | 19.6% |
| Net Profit Margin | 19.4% | 19.4% | 18.5% | 17.8% | 17.1% | 20.1% | 15.4% | 16.8% | 16.3% | 35.0% | 14.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 20.6% | 20.6% | 21.9% | 23.0% | 14.2% | 11.8% | 9.1% | 12.0% | 12.0% | 26.9% | 12.8% |
| ROA | 3.9% | 3.9% | 3.7% | 3.6% | 3.2% | 3.5% | 2.7% | 3.1% | 3.0% | 6.5% | 2.7% |
| ROIC | 13.4% | 13.4% | 13.8% | 14.4% | 10.0% | 9.0% | 6.9% | 8.8% | 8.9% | 10.3% | 10.4% |
| ROCE | 5.2% | 5.2% | 5.0% | 4.7% | 4.3% | 4.8% | 3.3% | 3.8% | 3.7% | 4.1% | 3.7% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.44 | 0.44 | 0.52 | 0.47 | 0.53 | 0.23 | 0.22 | 0.23 | 0.31 | 0.23 | 0.31 |
| Debt / EBITDA | 1.65 | 1.65 | 1.88 | 1.63 | 1.74 | 1.49 | 1.96 | 1.62 | 1.75 | 1.60 | 1.63 |
| Net Debt / Equity | — | 0.42 | 0.49 | 0.45 | 0.50 | 0.22 | 0.21 | 0.22 | 0.29 | 0.22 | 0.29 |
| Net Debt / EBITDA | 1.56 | 1.56 | 1.77 | 1.55 | 1.66 | 1.42 | 1.86 | 1.55 | 1.62 | 1.47 | 1.54 |
| Debt / FCF | — | 1.98 | 1.93 | 1.40 | 1.42 | 1.38 | 1.27 | 1.19 | 1.25 | 0.95 | 0.96 |
| Interest Coverage | 11.27 | 11.27 | 11.44 | 12.67 | 13.19 | 16.27 | 11.34 | 12.05 | 10.59 | 10.77 | 10.27 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.66 | 9.66 | 9.48 | 10.83 | 10.66 | 8.15 | — | — | — | — | — |
| Quick Ratio | 9.66 | 9.66 | 9.48 | 10.83 | 10.66 | 8.15 | — | — | — | — | — |
| Cash Ratio | 9.14 | 9.14 | 8.99 | 10.32 | 10.15 | 7.88 | — | — | — | — | — |
| Asset Turnover | — | 0.19 | 0.20 | 0.19 | 0.20 | 0.17 | 0.16 | 0.17 | 0.19 | 0.18 | 0.18 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.6% | 0.8% | 0.9% | 0.7% | 0.7% | 0.8% | 0.8% | 0.6% | 0.8% | 0.6% | 0.7% |
| Payout Ratio | 7.4% | 7.4% | 8.0% | 8.7% | 9.0% | 7.8% | 10.7% | 9.8% | 10.2% | 4.7% | 12.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 8.3% | 10.1% | 10.7% | 8.3% | 7.5% | 7.7% | 7.2% | 6.5% | 8.2% | 13.5% | 6.1% |
| FCF Yield | 9.6% | 11.1% | 14.1% | 12.2% | 11.7% | 14.5% | 14.1% | 11.3% | 14.3% | 13.1% | 15.2% |
| Buyback Yield | 6.7% | 7.8% | 10.6% | 4.4% | 3.8% | 5.6% | 4.4% | 3.9% | 4.9% | 3.8% | 4.5% |
| Total Shareholder Yield | 7.4% | 8.6% | 11.5% | 5.1% | 4.5% | 6.4% | 5.1% | 4.6% | 5.7% | 4.5% | 5.2% |
| Shares Outstanding | — | $81M | $85M | $96M | $99M | $103M | $107M | $111M | $115M | $119M | $122M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying GL stock.
Globe Life Inc.'s current P/E ratio is 12.0x. The historical average is 12.3x. This places it at the 40th percentile of its historical range.
Globe Life Inc.'s current EV/EBITDA is 9.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.1x.
Globe Life Inc.'s return on equity (ROE) is 20.6%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 14.8%.
Based on historical data, Globe Life Inc. is trading at a P/E of 12.0x. This is at the 40th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Globe Life Inc.'s current dividend yield is 0.63% with a payout ratio of 7.4%.
Globe Life Inc. has 33.4% gross margin and 24.4% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Globe Life Inc.'s Debt/EBITDA ratio is 1.6x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Severe mortality claim volatility
Metrics are mathematically derived from official filings.
Combined Ratio Swing Signals Severe Claim Shock
The combined ratio deteriorated dramatically from 76.4% in Q1 2026 to 139.4% in Q2 2026, a swing of over 63 points driven by a loss ratio spike to 150.3%, as reported in financial statements, indicating a major adverse claims event has destroyed underwriting profitability.
This extreme volatility suggests the underlying actuarial assumptions for claims costs may be inadequate or that a significant one-time mortality event has occurred, invalidating the underwriting margin expectations embedded in the stock's valuation. The sustainable earning power of the core business is now questionable, as the Q2 loss ratio is more than double the 10-quarter average prior to this quarter.
P/B Premium Ignores Underwriting Impairment
Despite the severe Q2 2026 underwriting loss, Globe Life's P/B of 2.38 remains at a premium to peers like Lincoln National (0.74) and Genworth (0.42), as indicated by reported market data, suggesting the market is pricing in normalized returns that the recent combined ratio of 139.4% severely challenges.
The premium likely reflects the perceived quality of the captive distribution model and historically stable renewals, but this ignores the immediate erosion of book value from an underwriting loss that wipes out nearly 40% of the equity base on an annualized basis. Investors should monitor whether the market rerates the P/B multiple downward to reflect the new risk profile implied by this claims volatility.
ROE Decoupled from Core Insurance Results
Globe Life reported a 4.7% ROE in Q2 2026, yet the combined ratio of 139.4% indicates core underwriting generated a substantial loss, implying that investment income and non-operating items are artificially supporting the headline return on equity.
This disconnect means the reported ROE is not a reliable indicator of the franchise's earning power; the true driver is the yield on float and capital management. The persistently low interest coverage ratio of -17.47 in Q2 further suggests that debt servicing is currently a burden that the underwriting operations cannot cover, placing greater emphasis on investment performance.
Expense Ratio Spike Masks Underlying Cost Structure
The implied expense ratio surged to -10.9% in Q2 2026 due to the massive premium shortfall relative to claims, which obscures the underlying administrative cost trend and makes it impossible to assess true operational efficiency in the most recent period.
Based on the historical quarters where the ratio was meaningful, the expense ratio has generally trended in the single digits, suggesting a relatively efficient operation. However, the Q2 anomaly indicates that the fixed-cost base is severe when premiums are overwhelmed by claims, and the company's operational leverage works violently in reverse during adverse claims cycles.
The Hazard of Simple P/E Valuation
The most misapplied ratio for Globe Life is likely the P/E, as the reported Q2 2026 net income of $287.7M masks a $629.6M operating loss from underwriting, meaning the multiple would be based on earnings distorted by non-operating items and accounting adjustments.
Using P/E creates a false sense of earnings security, as it incorporates volatile investment gains and reserve adjustments that do not reflect the health of the core insurance engine. A more appropriate metric is price-to-book (P/B) combined with a thorough analysis of the combined ratio trajectory, as this better captures the asset-backed nature of liabilities and the fundamental profitability of the underwriting cycle.